USPTO 2015–2025 USPTO PatentsView US Corporation

Aneuclose LLC

USPTO PatentsView assignee record - 14 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Aneuclose ranks #19,446 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 4 technology areas.

#19,446
of 49,997 US assignees by volume
Top 37%
by Innovation Score (39.8/100)
5.6
avg claims per patent
+80%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19446 · US Corporation #19,446 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #19,446/49,997
  • PHOTO-FINISH Amesite
  • CPC-NARROW A61B · 4 areas
  • INNOV-THIN 39.8/100
  • CLAIMS-SPARSE 5.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +80% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Amesite Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aneuclose’s 39.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Aneuclose

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Aneuclose's Innovation Score is 39.8/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Aneuclose?

Each dot is one of Aneuclose’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aneuclose’s own 5.6 claims/patent is at or below the 18.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aneuclose vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 010203040 Granted patents (volume) Avg claims / patent Amesite Inc. - 14, 13.5AmesiteAmylin Pharmaceuticals, LLC - 14, 11.64Amylin Pharmaceut…AnPac Bio-Medical Science Co., Ltd. - 14, 35.07Anpac Bio-medical…Andrew LLC - 14, 22.14AndrewAnji Henglin Technology Development Co., Ltd. - 14, 1Anji Henglin Tech…Aon Global Operations SE, Singapore Branch - 14, 18.5Aon Global Operat…Appy Risk Technologies Limited - 14, 18.93Appy RiskArbe Robotics Ltd. - 14, 18.5Arbe RoboticsAneuclose LLC - 14, 5.57Aneuclose
Aneuclose vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aneuclose's grants concentrate

Aneuclose LLC is a focused PatentsView assignee: 4 CPC subclasses with 92.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2016. By volume, Aneuclose sits between Amesite Inc. and Arbe Robotics Ltd..

Aneuclose's three-year grant acceleration

Aneuclose LLC shows 8 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Aneuclose's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Aneuclose holds 14 patents at rank #19,470, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Aneuclose

By rank, the assignees closest to #19,470 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Aneuclose's primary technology class.

Aneuclose's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2015201620182020202220232024 2
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Aneuclose LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 14.3%
2016 1 7.1%
2018 2 14.3%
2020 1 7.1%
2022 5 35.7%
2023 1 7.1%
2024 2 14.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Aneuclose LLC's patent record in context - here's where to go next.

  • Aneuclose LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 92.9% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #19,446 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Aneuclose LLC against Amesite Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.